drugset / Trial / NCT02202499
Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
Phase 0
Completed
86 enrolled
H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program · collabPfizer · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this Pilot feasibility study is to find out the effect of different behavioral treatments along with different duration of a drug called varenicline, on smoking behavior and quitting smoking. Varenicline, also known as Chantix™, is an FDA-approved medication that has been shown to help people quit smoking.
Timeline
- Start
- 2014-07-17
- Primary completion
- 2015-12-11
- Completion
- 2019-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varenicline | Small molecule | 1 mg | — |